Viewing Study NCT05583604


Ignite Creation Date: 2025-12-24 @ 9:19 PM
Ignite Modification Date: 2025-12-25 @ 7:06 PM
Study NCT ID: NCT05583604
Status: AVAILABLE
Last Update Posted: 2025-12-18
First Post: 2022-10-04
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Managed Access Programs for AIN457, Secukinumab
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module